The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis
Open accessAbstract
Background Tuberous sclerosis (TSC) is a multi‐system disorder caused by heterozygous mutations in the TSC1 or TSC2 gene and is often associated with neuropsychiatric symptoms, including intellectual disability, specific neuropsychological deficits, autism, other behavioural disorders and epilepsy. Method Here, we review evidence from animal models of TSC for the role of specific molecular and cellular processes in the pathogenesis of cognitive, developmental and epilepsy‐related manifestations seen in the disorder. Results Recent evidence shows that, in animal models, disinhibited mTOR (mammalian target of rapamycin) signalling substantially contributes to neuropsychiatric phenotypes, including cognitive deficits and seizures. We discuss potential pathogenetic mechanisms involved in the cognitive phenotypes of TSC and present implications regarding mTOR inhibitor‐based treatments for TSC‐related neuropsychiatric features. Conclusions Results suggest that reversing the underlying molecular deficits of TSC with rapamycin or other mTOR inhibitors could result in clinically significant improvements of cognitive function and neurological symptoms, even if treatments are started in adulthood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Frequently associated with deficits in long-term and working memory, along with intellectual disability, ASD, and epilepsy, TSC arises from heterozygous mutations in the TSC1 or TSC2 genes (Ehninger et al., 2009; Ehninger et al., 2008; Kong et al., 2014; Tsai et al., 2012).”
From Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (2016) · cites this paper as Ehninger et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505
K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons
Hoffman, D. A., Magee, J. C., Colbert, C. M., & Johnston, D. (1997) · Nature · doi:10.1038/43119 · Cited by 1,392
Cited by
Sorted by citations
Items 101–120 of 120
Sweet-Taste Receptor Signaling Network and Low-Calorie Sweeteners
Welcome, M. O., Mastorakis, N. E., & Pereverzev, V. A. (2018) · Reference series in phytochemistry · doi:10.1007/978-3-319-27027-2_25 · Cited by 1
Brain Plasticity and its Disorders
Johnston, M. V. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00013-5 · Cited by 1
Tuberous Sclerosis Complex and the Mammalian Target of Rapamycin Pathways
Yu, J. J. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022388 · Cited by 1
Modern Approaches to Diagnosis and Treatment of Cognitive Disorders in Children and Adults
Gorbachevskaya, N. L. (2010) · Psychological Science and Education psyedu.ru
Toward Fulfilling the Promise of Molecular Medicine in Fragile X
Krueger‐Burg, D., & Bear, M. F. (2011) · DSpace@MIT (Massachusetts Institute of Technology)
Kalogerou, M. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Novel Therapeutics in Autism Spectrum Disorders
Anagnostou, E. A., McKeever, C., & Kushki, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00007-7
Pathology and treatment of autism spectrum disorders
Kotajima‐Murakami, H., Sato, A., & Ikeda, K. (2015) · Folia Pharmacologica Japonica · doi:10.1254/fpj.145.193
Social phenotypes in genetic syndromes
Swillen, A., de Ravel, T. J. L., & Oliver, C. (2012) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2012.01620.x
Regulation of the Target of Rapamycin Signaling Pathway in Saccharomyces cerevisiae
Pracheil, T. (2013) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
IMPLICATIONS OF MITOTIC ONSET REGULATION IN TUBEROUS SCLEROSIS
Dare-Shih, J. (2016) · Scholarship at UWindsor (University of Windsor)
New Perspectives in Autism Spectrum Disorder associated with Tuberous Sclerosis
Benvenuto, A., Graziola, F., Moavero, R., Mazzone, L., Gialloreti, L. E., Curatolo, P., & Siracusano, M. (2017) · Journal of Pediatric Neurology · doi:10.1055/s-0037-1601445
Everolimus y astrocitoma subependimario de células gigantes con degeneración quística.
Restrepo, C. E., Cardona, A. F., Mayor, L. C., & Jiménez, E. (2012) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.315
Excessive Cap-dependent Translation as a Molecular Mechanism Underlying ASD
Klann, E. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada612864
Nairn, A. C., & Wiseman, S. L. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13385959.14754080
Targeting Ferroptosis in Tuberous Sclerosis Cell Line Models
Tahsin, T. (2025) · Cronfa (Swansea University) · doi:10.23889/suthesis.69835
The Role of the New mTOR Complex, MTORC2, in Autism Spectrum Disorders
Costa‐Mattioli, M. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada613836
Dai, F. W., Duan, Y., Di, B.-A., Feng, Q., Cui, J., & Lv, T. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1772908
Ding, R., Meng, L., Hong, S., Guo, Y., Cheng, M., Hu, Y., Luo, Y., Jiang, L., & Xie, L. (2026) · Seizure · doi:10.1016/j.seizure.2026.04.002
Metadata
- Authors
- Ehninger, D., De Vries, P. J., & Silva, A. J.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ehninger, D.
- Venue
- Journal of Intellectual Disability Research
- Publisher
- Wiley
- Published
- 2009-09-25
- Volume
- 53
- Issue
- 10
- Pages
- 838-851
- ISSN
- 0964-2633 (ISSN-L)
- 1365-2788
- PMC
- PMC2844770
- OpenAlex
- W1981844658
- Cited by
- 120
- References
- 108
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2022: 5 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 24
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Intellectual Disability Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS038480)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- tuberous sclerosis complex, mTOR signaling, cognitive impairment, intellectual disability, epilepsy, neuropsychiatric symptoms, TSC1, TSC2, rapamycin, mTOR inhibitors, animal models, autism spectrum disorder, developmental disorders
- MeSH terms
- Animals, Behavior, Animal, Carrier Proteins, Cognition, Cognition Disorders, Cell Biology, Disease Models, Animal, Epilepsy, Humans, Molecular Biology, Risk Factors, Tuberous Sclerosis, Phosphotransferases (Alcohol Group Acceptor), Mice, Rats, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
